342 related articles for article (PubMed ID: 30256033)
1. Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.
Shahriari A; Habibi-Pirkoohi M
Arch Razi Inst; 2018 Dec; 73(1):1-10. PubMed ID: 30256033
[TBL] [Abstract][Full Text] [Related]
2. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
Rodriguez LL; Gay CG
Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
[TBL] [Abstract][Full Text] [Related]
3. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
4. Foot-and-mouth disease vaccines: progress and problems.
Cao Y; Lu Z; Liu Z
Expert Rev Vaccines; 2016 Jun; 15(6):783-9. PubMed ID: 26760264
[TBL] [Abstract][Full Text] [Related]
5. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
6. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
[TBL] [Abstract][Full Text] [Related]
7. Targeted FMD Vaccines for Eastern Africa: The AgResults Foot and Mouth Disease Vaccine Challenge Project.
Hammond JM; Maulidi B; Henning N
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578411
[TBL] [Abstract][Full Text] [Related]
8. Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.
Robinson L; Knight-Jones TJ; Charleston B; Rodriguez LL; Gay CG; Sumption KJ; Vosloo W
Transbound Emerg Dis; 2016 Jun; 63 Suppl 1():30-41. PubMed ID: 27320164
[TBL] [Abstract][Full Text] [Related]
9. Foot and mouth disease virus vaccines.
Rodriguez LL; Grubman MJ
Vaccine; 2009 Nov; 27 Suppl 4():D90-4. PubMed ID: 19837296
[TBL] [Abstract][Full Text] [Related]
10. Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids.
Mignaqui AC; Ruiz V; Durocher Y; Wigdorovitz A
Crit Rev Biotechnol; 2019 May; 39(3):306-320. PubMed ID: 30654663
[TBL] [Abstract][Full Text] [Related]
11. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
12. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
[TBL] [Abstract][Full Text] [Related]
13. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
[TBL] [Abstract][Full Text] [Related]
15. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
[TBL] [Abstract][Full Text] [Related]
16. Prospects, including time-frames, for improved foot and mouth disease vaccines.
Grubman MJ; Mason PW
Rev Sci Tech; 2002 Dec; 21(3):589-600. PubMed ID: 12523699
[TBL] [Abstract][Full Text] [Related]
17. [Expression of foot and mouth disease virus antigens in transgenic plants].
Dus Santos MJ; Wigdorovitz A
Rev Sci Tech; 2005 Apr; 24(1):175-87. PubMed ID: 16110887
[TBL] [Abstract][Full Text] [Related]
18. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
[TBL] [Abstract][Full Text] [Related]
19. Past and present vaccine development strategies for the control of foot-and-mouth disease.
Balamurugan V; Kumar RM; Suryanarayana VV
Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to foot-and-mouth disease vaccine development.
Ludi A; Rodriguez L
Dev Biol (Basel); 2013; 135():107-16. PubMed ID: 23689888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
